Stomach cancer CT

Jump to navigation Jump to search

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [2]

Stomach cancer Microchapters


Patient Information


Historical Perspective




Differentiating Stomach Cancer from other Diseases

Epidemiology and Demographics

Risk Factors


Natural History, Complications and Prognosis


Diagnostic study of choice


History and Symptoms

Physical Examination

Laboratory Findings

Endoscopy and Biopsy

Chest X Ray



Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies


Medical Therapy


Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Stomach cancer CT On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides


American Roentgen Ray Society Images of Stomach cancer CT

All Images
Echo & Ultrasound
CT Images

Ongoing Trials at Clinical

US National Guidelines Clearinghouse

NICE Guidance

FDA on Stomach cancer CT

CDC on Stomach cancer CT

Stomach cancer CT in the news

Blogs on Stomach cancer CT

Directions to Hospitals Treating Stomach cancer

Risk calculators and risk factors for Stomach cancer CT


Abdominal CT scan may be helpful in the diagnosis of stomach cancer. It is used to evaluate metastatic disease, especially hepatic or adnexal metastases, ascites, or distant nodal spread. Integrated PET/CT imaging can be useful to confirm malignant involvement of CT-detected lymphadenopathy. A negative PET CT is not helpful, since even large tumors with a diameter of several centimeters may not be visible on PET scan if the tumor cells have a fairly low metabolic activity.

CT scan

Demonstration of lesions facilitated by negative contrast agents:[4]

CT shows gastric cancer, source: Case courtesy of Dr Hani Salam,, rID: 10722

PET/CT scan 

PET CT shows gastric cancer, source: Case courtesy of Dr Hani Salam,, rID: 10722


  1. Sussman SK, Halvorsen RA, Illescas FF, Cohan RH, Saeed M, Silverman PM; et al. (1988). "Gastric adenocarcinoma: CT versus surgical staging". Radiology. 167 (2): 335–40. doi:10.1148/radiology.167.2.3357941. PMID 3357941.
  2. Kim SJ, Kim HH, Kim YH, Hwang SH, Lee HS, Park DJ; et al. (2009). "Peritoneal metastasis: detection with 16- or 64-detector row CT in patients undergoing surgery for gastric cancer". Radiology. 253 (2): 407–15. doi:10.1148/radiol.2532082272. PMID 19789243.
  3. Kienle P, Buhl K, Kuntz C, Düx M, Hartmann C, Axel B; et al. (2002). "Prospective comparison of endoscopy, endosonography and computed tomography for staging of tumours of the oesophagus and gastric cardia". Digestion. 66 (4): 230–6. doi:10.1159/000068360. PMID 12592099.
  5. Yun M, Lim JS, Noh SH, Hyung WJ, Cheong JH, Bong JK; et al. (2005). "Lymph node staging of gastric cancer using (18)F-FDG PET: a comparison study with CT". J Nucl Med. 46 (10): 1582–8. PMID 16204706.
  6. Stahl A, Ott K, Weber WA, Becker K, Link T, Siewert JR; et al. (2003). "FDG PET imaging of locally advanced gastric carcinomas: correlation with endoscopic and histopathological findings". Eur J Nucl Med Mol Imaging. 30 (2): 288–95. doi:10.1007/s00259-002-1029-5. PMID 12552348.
  7. Kinkel K, Lu Y, Both M, Warren RS, Thoeni RF (2002). "Detection of hepatic metastases from cancers of the gastrointestinal tract by using noninvasive imaging methods (US, CT, MR imaging, PET): a meta-analysis". Radiology. 224 (3): 748–56. doi:10.1148/radiol.2243011362. PMID 12202709.
  8. Yoshioka T, Yamaguchi K, Kubota K, Saginoya T, Yamazaki T, Ido T; et al. (2003). "Evaluation of 18F-FDG PET in patients with advanced, metastatic, or recurrent gastric cancer". J Nucl Med. 44 (5): 690–9. PMID 12732669.

Template:WH Template:WS